Viewing Study NCT07082868


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-01-02 @ 9:29 AM
Study NCT ID: NCT07082868
Status: RECRUITING
Last Update Posted: 2025-10-20
First Post: 2025-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module